BPA Call W81XWH22A0001-HT009026FG0110004
- Not listed
- Harvard Bioscience Inc., operating through its Data Sciences International division, was awarded a $36,356 firm fixed-price Blanket Purchase Agreement call order by the Defense Health Agency on October 17, 2025, for DSI telemetry system expansion and upgrade work. This task order is issued under Harvard Bioscience's existing $4.8 million single-award BPA with the Defense Health Agency, which was originally awarded in May 2022 and extends through May 3, 2027. The BPA serves as an indefinite...
- Harvard Bioscience Inc., operating through its Data Sciences International division, was awarded a $22,386 firm fixed-price call order under the Defense Health Agency's single-award Blanket Purchase Agreement on October 2, 2025. This task order, which carries an ultimate completion date of September 30, 2026, is designated for the closeout and replenishment of supplies spent by a funded project and will be performed at the company's Mounds View, Minnesota facility. The call represents the latest...
- Harvard Bioscience Inc., operating through its Data Sciences International division, received a Blanket Purchase Agreement (BPA) call order valued at $8,320.00 from the Defense Health Agency on May 4, 2022, with an ultimate completion date of July 31, 2023. This firm fixed-price task order was issued under Harvard Bioscience's single-award, $4.8 million BPA with the Defense Health Agency, which was awarded on the same date with a completion extending through May 3, 2027. The call order...
- Harvard Bioscience Inc., operating through its Data Sciences International division, received a $143,577 firm fixed-price Blanket Purchase Agreement (BPA) call order from the U.S. Army Medical Command on July 27, 2022, for telemetry software and systems. The award was issued without a set-aside designation and is scheduled for completion by August 31, 2022. Performance will be conducted at the company's Mounds View, Minnesota facility. This call order represents one task order within Harvard...
- Harvard Bioscience Inc., operating through its Data Sciences International division, received a $75,394.99 firm fixed-price Blanket Purchase Agreement call order from the Defense Health Agency for the purchase of telemetry transmitter devices used to track the health of research animals, as well as telemetry implant refurbishments and exchanges. The contract, awarded on April 1, 2024, with an ultimate completion date of May 31, 2025, will be performed at Aberdeen Proving Ground in Maryland. This...
- Harvard Bioscience Inc., operating through its Data Sciences International division, received a Blanket Purchase Agreement (BPA) call order valued at $11.4K from the Defense Health Agency (Military Command) on June 28, 2023, for implant exchanges required under the 1121 Protocol. This firm fixed-price task order, which was not set-aside, is scheduled for completion by September 30, 2023, with performance taking place in Mounds View, Minnesota. The award represents a continuation of Harvard...
- The Defense Health Agency awarded a $16,295 firm fixed-price call order to Harvard Bioscience Inc., operating through its Data Sciences International division, on July 14, 2023, for telemetry implants with an ultimate completion date of September 30, 2023. This award represents a task order issued under Harvard Bioscience's existing $4.8 million single-award Blanket Purchase Agreement with the Defense Health Agency, which was established on May 4, 2022, and extends through May 3, 2027. The BPA...
- Harvard Bioscience Inc., operating through its Data Sciences International division, received a $17,910.30 firm fixed-price call order under a Blanket Purchase Agreement with the Defense Health Agency on March 10, 2023. The award covers aerosol equipment to be delivered to Mounds View, Minnesota, with an ultimate completion date of September 30, 2023. This contract represents a non-set-aside procurement issued without a small business set-aside designation. Harvard Bioscience is a self-certified...
- Harvard Bioscience Inc., operating through its Data Sciences International division, was awarded a call order valued at $85,106 under a Blanket Purchase Agreement with the Defense Health Agency on May 4, 2022. The contract, designated as 270-0173-001 HD-S02 IMPLANT, is structured as a firm fixed-price purchase order with an ultimate completion date of May 31, 2022. The award was not designated as a set-aside. Performance will be conducted at the company's Mounds View, Minnesota facility, which...
- Harvard Bioscience Inc., operating through its Data Sciences International division, was awarded a $62,630 firm fixed-price call order under a Blanket Purchase Agreement (BPA) with the Defense Health Agency on September 6, 2022. This task order, designated M11 IMPLANT (270-0411-06-01-F1), calls for the delivery of M11 implantable telemetry devices and related biomedical research equipment to support physiological monitoring applications in preclinical research. The award utilizes the Defense...
- W81XWH22A0001Blanket Purchase Agreement
- W81XWH22A0001-HT009026FG0110004BPA Call
Harvard Bioscience Inc., operating through its Data Sciences International (DSI) division, was awarded a $21,591 firm fixed-price call order by the Defense Health Agency on January 14, 2026, for telemetry equipment and software. This award is a task order issued under Harvard Bioscience's existing single-award Blanket Purchase Agreement with the Defense Health Agency valued at $4.8 million (awarded May 4, 2022, with completion date of May 3, 2027). The BPA serves as an indefinite delivery vehicle enabling the Defense Health Agency, Army Medical Command, and other military health system partners to procure specialized biomedical research solutions, and this particular call order represents one of many task orders executed under that agreement, with cumulative procurement value exceeding $1.5 million. The work will be performed at Harvard Bioscience's facility in Mounds View, Minnesota, with an ultimate completion date of September 30, 2026. No set-aside designation was used for this award. Harvard Bioscience is a self-certified small disadvantaged business headquartered in New Brighton, Minnesota, specializing in advanced physiological monitoring technologies including wireless implantable telemetry transmitters, respiratory monitoring systems, data acquisition software, and related research instrumentation used in preclinical studies and medical research. The company has established itself as a critical supplier to multiple federal agencies across the Department of Defense, National Institutes of Health, Department of Veterans Affairs, and other civilian research agencies, delivering sophisticated biomedical equipment that enables complex physiological research across defense and military healthcare sectors.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $21.6k | 1/13/26 |